BDBM648843 8-(1,1-difluoro-5-azaspiro[2.4]heptan-5-yl)-6- methyl-N-(1-(methylsulfonyl)piperidin-4- yl)pyrido[3,4-d]pyrimidin-2-amine::US20240034731, Compound 41

SMILES Cc1cc2cnc(NC3CCC(S(C)(=O)=O)CC3)nc2c(N2CCC3(C2)CC3(F)F)n1

InChI Key InChIKey=LGMROHYTYOGNIY-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 648843   

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Iambic Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648843BDBM648843(8-(1,1-difluoro-5-azaspiro[2.4]heptan-5-yl)-6- met...)
Affinity DataIC50: 200nMAssay Description:The purpose of CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition and IC50 values) of small molecule inhibitors by using a Luminescent ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Iambic Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648843BDBM648843(8-(1,1-difluoro-5-azaspiro[2.4]heptan-5-yl)-6- met...)
Affinity DataIC50: 200nMAssay Description:The purpose of CDK4/Cyclin D1 assay is to evaluate the inhibition (% inhibition and IC50 values) of small molecule inhibitors by using a Chelation-En...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 4/6(Human)
Iambic Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648843BDBM648843(8-(1,1-difluoro-5-azaspiro[2.4]heptan-5-yl)-6- met...)
Affinity DataIC50: 200nMAssay Description:The purpose of the CDK6/Cyclin D3 assay is to evaluate the inhibition (% inhibition and IC50 values) in the presence of small molecule inhibitors by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Iambic Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648843BDBM648843(8-(1,1-difluoro-5-azaspiro[2.4]heptan-5-yl)-6- met...)
Affinity DataIC50: 200nMAssay Description:The purpose of CDK1/Cyclin B1 assay is to evaluate the inhibition (% inhibition and IC50 values) of small molecule inhibitors by using a Luminescent ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent